Aurinia Pharmaceuticals Inc (AUPH)
9.03
-0.01
(-0.11%)
USD |
NASDAQ |
Dec 20, 16:00
9.035
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Profit Margin (Quarterly): 21.17% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -2.60K% |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |
| ImmunoPrecise Antibodies Ltd | -41.68% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -5.99% |
| Return on Assets | -4.19% |
| Return on Invested Capital | -5.99% |
| Gross Profit Margin (Quarterly) | 91.10% |
| Operating Margin (Quarterly) | 17.33% |
| Return on Net Operating Assets | -11.47% |